Octagon Capital invests in public and private healthcare companies globally.
Octagon Capital invests in public and private healthcare companies globally. Octagon Capital focuses on strategic long-term investments and strive to work with our portfolio management teams as partners.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Apr 29, 2021
Forge Biologics
|
Series B | $120M | Biotechnology | — |
Mar 22, 2021
EpimAb Biotherapeutics
|
Series C | $120M | Biopharma | — |